Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02912364 · ClinicalTrials.gov registry record · Phase 4
Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT02912364: Completed Phase 4 study, sponsored by Stanford University.
NCT02912364 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02912364, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
Double-blind, randomized, two period crossover comparison of the cognitive and behavioral effects of Eslicarbazepine acetate and Carbamazepine in healthy volunteers.
Interventions
- DRUG Carbamazepine
- DRUG Eslicarbazepine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-04-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02912364
The ClinicalTrials.gov registry entry for NCT02912364 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Carbamazepine is the first listed.
NCT02912364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02912364 about?
NCT02912364 is a clinical study titled "Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults". Double-blind, randomized, two period crossover comparison of the cognitive and behavioral effects of Eslicarbazepine acetate and Carbamazepine in healthy volunteers.
What is the current status of trial NCT02912364?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2016-07. Estimated completion is 2018-04-20.
What interventions are being tested in trial NCT02912364?
The interventions under investigation include: Carbamazepine (DRUG), Eslicarbazepine (DRUG).
Who is sponsoring clinical trial NCT02912364?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.